Rx Systems
Pharmacy software to the pharmacy market.
Financials
Estimates*
| EUR | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenues | 22.1m | 24.0m | 25.7m | 26.3m | 30.1m | 36.0m | 33.0m |
| % growth | 8 % | 9 % | 7 % | 2 % | 14 % | 20 % | (8 %) |
| EBITDA | 5.9m | 7.4m | 8.1m | 6.4m | 8.2m | 11.1m | 11.2m |
| % EBITDA margin | 27 % | 31 % | 32 % | 24 % | 27 % | 31 % | 34 % |
| Profit | 4.7m | 5.2m | 6.7m | 5.4m | 7.1m | 8.6m | 9.2m |
| % profit margin | 21 % | 22 % | 26 % | 21 % | 24 % | 24 % | 28 % |
| R&D budget | - | - | - | 2.2m | 1.8m | 2.1m | 2.1m |
| R&D % of revenue | - | - | - | 8 % | 6 % | 6 % | 6 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
N/A | Acquisition | ||
| Total Funding | - | ||